Evidence map›Paper›PMID 30890638›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.

Vinit Shanbhag, Kimberly Jasmer-McDonald, Sha Zhu, Adam L Martin, Nikita Gudekar, Aslam Khan, Erik Ladomersky, Kamlendra Singh, Gary A Weisman, Michael J Petris

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 2 syntheses or guidelines pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Enzymatic and non-enzymatic oxidation of fibrillar collagen.Redox report : communications in free radical research · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Copper, cuproptosis, and cancer: biology concepts of a novel cell death.Apoptosis : an international journal on programmed cell death · 2026
    Review
  8. Balancing cellular copper levels via the post-translational regulation of copper transport.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  9. Review
  10. Review
  11. Copper dysregulation in cardiometabolic disease: copper deficiency versus cuproptosis.Apoptosis : an international journal on programmed cell death · 2026
    Review
  12. Review
  13. Article
  14. A broad-spectrum inhibitor of copper-exporting PProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. FOXC1-ATP7A Axis Activates PI3K/AKT Signaling to Suppress Cuproptosis and Drive Fibroblast Pathogenesis in Rheumatoid Arthritis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  16. Article
  17. Article
  18. Ultrasound-activated nanoregulator enables CuJournal of nanobiotechnology · 2026
    Article
  19. Article
  20. Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Vinit ShanbhagDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Kimberly Jasmer-McDonaldDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Sha ZhuDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Adam L MartinDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Nikita GudekarThe Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Aslam KhanDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Erik LadomerskyDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Kamlendra SinghThe Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Gary A WeismanDepartment of Biochemistry, University of Missouri, Columbia, MO 65211.
Michael J PetrisDepartment of Biochemistry, University of Missouri, Columbia, MO 65211; petrism@missouri.edu.
University of Missouri · US

Funding

Copper metabolism as a unique vulnerability in cancerR01CA190265 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PETRIS, MICHAEL J. · 2015 to 2019
$1.7M
NCI NIH HHS R01 CA190265
6 · The paper itself

Abstract

Lysyl oxidase (LOX) and LOX-like (LOXL) proteins are copper-dependent metalloenzymes with well-documented roles in tumor metastasis and fibrotic diseases. The mechanism by which copper is delivered to these enzymes is poorly understood. In this study, we demonstrate that the copper transporter ATP7A is necessary for the activity of LOX and LOXL enzymes. Silencing of ATP7A inhibited LOX activity in the 4T1 mammary carcinoma cell line, resulting in a loss of LOX-dependent mechanisms of metastasis, including the phosphorylation of focal adhesion kinase and myeloid cell recruitment to the lungs, in an orthotopic mouse model of breast cancer. ATP7A silencing was also found to attenuate LOX activity and metastasis of Lewis lung carcinoma cells in mice. Meta-analysis of breast cancer patients found that high ATP7A expression was significantly correlated with reduced survival. Taken together, these results identify ATP7A as a therapeutic target for blocking LOX- and LOXL-dependent malignancies.

Indexed as

AnimalsBreast NeoplasmsCarcinoma, Lewis LungCopperCopper-Transporting ATPasesFemaleHumansIon TransportMaleMammary Neoplasms, AnimalMeta-Analysis as TopicMiceMice, Inbred BALB CNeoplasm MetastasisNeoplasm ProteinsProtein-Lysine 6-OxidaseAtp7a protein, mouseCopperCopper-Transporting ATPasesNeoplasm ProteinsProtein-Lysine 6-Oxidasebreast cancercopperlung cancerlysyl oxidasemetastasis

Identifiers

PMID30890638
PMCPMC6452744
OpenAlexW2924678213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.